Annual Operating Profit:
$7.73M+$13.32M(+237.99%)Summary
- As of today, CDXC annual operating income is $7.73 million, with the most recent change of +$13.32 million (+237.99%) on December 31, 2024.
- During the last 3 years, CDXC annual operating profit has risen by +$34.80 million (+128.54%).
Performance
CDXC Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly Operating Profit:
$4.77M-$2.34M(-32.89%)Summary
- As of today, CDXC quarterly operating income is $4.77 million, with the most recent change of -$2.34 million (-32.89%) on March 31, 2025.
- Over the past year, CDXC quarterly operating profit has increased by +$5.50 million (+752.80%).
Performance
CDXC Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
TTM Operating Profit:
$13.23M+$5.50M(+71.23%)Summary
- As of today, CDXC TTM operating income is $13.23 million, with the most recent change of +$5.50 million (+71.23%) on March 31, 2025.
- Over the past year, CDXC TTM operating profit has increased by +$17.59 million (+403.28%).
Performance
CDXC TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
CDXC Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +238.0% | +752.8% | +403.3% |
| 3Y3 Years | +128.5% | +161.7% | +148.2% |
| 5Y5 Years | +124.7% | +181.0% | +158.4% |
CDXC Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +128.5% | -32.9% | +255.7% | at high | +158.8% |
| 5Y | 5-Year | at high | +124.7% | -32.9% | +154.0% | at high | +146.8% |
| All-Time | All-Time | at high | +123.3% | -32.9% | +153.9% | at high | +139.2% |
CDXC Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $4.77M(-32.9%) | $13.23M(+71.2%) |
| Dec 2024 | $7.73M(+238.0%) | $7.11M(+343.9%) | $7.73M(+1628.4%) |
| Sep 2024 | - | $1.60M(+725.8%) | $447.00K(+119.4%) |
| Jun 2024 | - | -$256.00K(+65.0%) | -$2.30M(+47.2%) |
| Mar 2024 | - | -$731.00K(-335.1%) | -$4.36M(+22.1%) |
| Dec 2023 | -$5.60M(+69.9%) | -$168.00K(+85.4%) | -$5.60M(+18.6%) |
| Sep 2023 | - | -$1.15M(+50.5%) | -$6.88M(+21.8%) |
| Jun 2023 | - | -$2.32M(-17.7%) | -$8.79M(+31.6%) |
| Mar 2023 | - | -$1.97M(-36.3%) | -$12.86M(+30.9%) |
| Dec 2022 | -$18.63M(+31.2%) | -$1.44M(+52.9%) | -$18.63M(+17.2%) |
| Sep 2022 | - | -$3.06M(+52.0%) | -$22.50M(+20.4%) |
| Jun 2022 | - | -$6.39M(+17.4%) | -$28.28M(-3.0%) |
| Mar 2022 | - | -$7.73M(-45.4%) | -$27.44M(-1.4%) |
| Dec 2021 | -$27.07M(-36.4%) | -$5.32M(+39.9%) | -$27.07M(+2.7%) |
| Sep 2021 | - | -$8.84M(-59.2%) | -$27.84M(-20.0%) |
| Jun 2021 | - | -$5.55M(+24.6%) | -$23.19M(-8.8%) |
| Mar 2021 | - | -$7.36M(-21.1%) | -$21.33M(-7.4%) |
| Dec 2020 | -$19.85M(+36.6%) | -$6.08M(-44.9%) | -$19.85M(+12.3%) |
| Sep 2020 | - | -$4.20M(-13.8%) | -$22.63M(+10.6%) |
| Jun 2020 | - | -$3.69M(+37.4%) | -$25.32M(+12.1%) |
| Mar 2020 | - | -$5.89M(+33.5%) | -$28.82M(+7.9%) |
| Dec 2019 | -$31.30M(+5.6%) | -$8.86M(-28.6%) | -$31.30M(-2.0%) |
| Sep 2019 | - | -$6.89M(+4.1%) | -$30.68M(+5.3%) |
| Jun 2019 | - | -$7.18M(+14.2%) | -$32.39M(+2.3%) |
| Mar 2019 | - | -$8.37M(-1.6%) | -$33.15M(+0.1%) |
| Dec 2018 | -$33.17M(-102.6%) | -$8.24M(+4.1%) | -$33.17M(+1.6%) |
| Sep 2018 | - | -$8.60M(-8.3%) | -$33.71M(-19.2%) |
| Jun 2018 | - | -$7.94M(+5.5%) | -$28.29M(-23.0%) |
| Mar 2018 | - | -$8.40M(+4.3%) | -$23.00M(-40.5%) |
| Dec 2017 | -$16.38M(-463.7%) | -$8.78M(-176.4%) | -$16.38M(-67.6%) |
| Sep 2017 | - | -$3.18M(-19.8%) | -$9.77M(-29.9%) |
| Jun 2017 | - | -$2.65M(-49.5%) | -$7.52M(-67.2%) |
| Mar 2017 | - | -$1.77M(+18.4%) | -$4.50M(-98.1%) |
| Dec 2016 | -$2.91M | -$2.17M(-135.0%) | -$2.27M(-81.4%) |
| Sep 2016 | - | -$924.20K(-349.0%) | -$1.25M(-730.3%) |
| Jun 2016 | - | $371.10K(-18.3%) | -$150.80K(+78.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $454.10K(+139.4%) | -$706.00K(+65.8%) |
| Dec 2015 | -$2.07M(+60.2%) | -$1.15M(-751.1%) | -$2.07M(-3.7%) |
| Sep 2015 | - | $177.10K(+196.2%) | -$1.99M(+29.3%) |
| Jun 2015 | - | -$184.10K(+79.7%) | -$2.82M(+34.1%) |
| Mar 2015 | - | -$906.10K(+16.1%) | -$4.27M(+17.6%) |
| Dec 2014 | -$5.19M(-19.4%) | -$1.08M(-66.7%) | -$5.19M(-7.8%) |
| Sep 2014 | - | -$647.40K(+60.6%) | -$4.81M(+10.4%) |
| Jun 2014 | - | -$1.64M(+9.7%) | -$5.37M(-13.2%) |
| Mar 2014 | - | -$1.82M(-158.3%) | -$4.74M(-9.2%) |
| Dec 2013 | -$4.34M(+62.7%) | -$703.40K(+41.8%) | -$4.34M(+18.6%) |
| Sep 2013 | - | -$1.21M(-19.3%) | -$5.33M(+5.7%) |
| Jun 2013 | - | -$1.01M(+28.5%) | -$5.65M(+34.5%) |
| Mar 2013 | - | -$1.42M(+16.3%) | -$8.63M(+25.9%) |
| Dec 2012 | -$11.64M(-48.0%) | -$1.69M(-10.5%) | -$11.64M(+6.4%) |
| Sep 2012 | - | -$1.53M(+61.6%) | -$12.43M(+6.5%) |
| Jun 2012 | - | -$3.99M(+9.9%) | -$13.29M(-19.3%) |
| Mar 2012 | - | -$4.42M(-78.1%) | -$11.14M(-41.7%) |
| Dec 2011 | -$7.86M(-289.9%) | -$2.48M(-3.6%) | -$7.86M(-25.4%) |
| Sep 2011 | - | -$2.40M(-30.7%) | -$6.27M(-32.1%) |
| Jun 2011 | - | -$1.83M(-59.8%) | -$4.75M(-48.1%) |
| Mar 2011 | - | -$1.15M(-29.0%) | -$3.20M(-58.9%) |
| Dec 2010 | -$2.02M(-126.0%) | -$889.60K(-1.8%) | -$2.02M(-62.7%) |
| Sep 2010 | - | -$873.70K(-198.0%) | -$1.24M(-129.7%) |
| Jun 2010 | - | -$293.20K(-846.1%) | -$539.50K(-1.2%) |
| Mar 2010 | - | $39.30K(+135.1%) | -$533.20K(+40.3%) |
| Dec 2009 | -$892.70K(+56.7%) | -$111.90K(+35.6%) | -$892.70K(+36.5%) |
| Sep 2009 | - | -$173.70K(+39.5%) | -$1.41M(+27.2%) |
| Jun 2009 | - | -$286.90K(+10.4%) | -$1.93M(+14.9%) |
| Mar 2009 | - | -$320.20K(+48.7%) | -$2.27M(-16.3%) |
| Dec 2008 | -$2.06M(-5275.0%) | -$624.40K(+10.6%) | -$1.95M(-47.0%) |
| Sep 2008 | - | -$698.40K(-11.6%) | -$1.33M(-108.5%) |
| Jun 2008 | - | -$626.00K(>-9900.0%) | -$636.70K(-4581.6%) |
| Feb 2008 | - | -$2900.00(+17.1%) | -$13.60K(+41.6%) |
| Nov 2007 | -$38.40K | -$3500.00(+18.6%) | -$23.30K(-17.7%) |
| Aug 2007 | - | -$4300.00(-48.3%) | -$19.80K(-27.7%) |
| May 2007 | - | -$2900.00(+77.0%) | -$15.50K(-23.0%) |
| Feb 2007 | - | -$12.60K | -$12.60K |
FAQ
- What is Niagen Bioscience, Inc. annual operating income?
- What is the all-time high annual operating profit for Niagen Bioscience, Inc.?
- What is Niagen Bioscience, Inc. annual operating profit year-on-year change?
- What is Niagen Bioscience, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Niagen Bioscience, Inc.?
- What is Niagen Bioscience, Inc. quarterly operating profit year-on-year change?
- What is Niagen Bioscience, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Niagen Bioscience, Inc.?
- What is Niagen Bioscience, Inc. TTM operating profit year-on-year change?
What is Niagen Bioscience, Inc. annual operating income?
The current annual operating profit of CDXC is $7.73M
What is the all-time high annual operating profit for Niagen Bioscience, Inc.?
Niagen Bioscience, Inc. all-time high annual operating income is $7.73M
What is Niagen Bioscience, Inc. annual operating profit year-on-year change?
Over the past year, CDXC annual operating income has changed by +$13.32M (+237.99%)
What is Niagen Bioscience, Inc. quarterly operating income?
The current quarterly operating profit of CDXC is $4.77M
What is the all-time high quarterly operating profit for Niagen Bioscience, Inc.?
Niagen Bioscience, Inc. all-time high quarterly operating income is $7.11M
What is Niagen Bioscience, Inc. quarterly operating profit year-on-year change?
Over the past year, CDXC quarterly operating income has changed by +$5.50M (+752.80%)
What is Niagen Bioscience, Inc. TTM operating income?
The current TTM operating profit of CDXC is $13.23M
What is the all-time high TTM operating profit for Niagen Bioscience, Inc.?
Niagen Bioscience, Inc. all-time high TTM operating income is $13.23M
What is Niagen Bioscience, Inc. TTM operating profit year-on-year change?
Over the past year, CDXC TTM operating income has changed by +$17.59M (+403.28%)